Agner A R, Maciel M A, Pinto A C, Cólus I M
Departamento de Biologia Geral, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina (Pr), Brazil.
Planta Med. 2001 Dec;67(9):815-9. doi: 10.1055/s-2001-18855.
The antigenotoxic action of three doses of trans-dehydrocrotonin (t-DCTN), the active ingredient obtained from the bark extract of Croton cajucara, a plant native to the Amazon, was determined in Swiss mice in vivo. Mice were submitted to acute intraperitoneal and gavage treatments, then their bone marrow cells were subsequently analyzed by micronucleus (MN) and chromosome aberration (CA) assays. Comparisons were performed between the three doses of t-DCTN and the negative-control group. Statistical analysis indicated that doses of 50 and 75 % of the LD(50), via intraperitoneal treatment or gavage injection, were antimutagenic with regard to cyclophosphamide. However, the dose of 25 % of the LD(50) was only antimutagenic when administered by gavage. Based on these observations, it can be suggested that gavage is the most effective method of administering t-DCTN. In addition, t-DCTN showed no cytotoxic effects in the bone marrow cells regardless of the route of exposure.
测定了从原产于亚马逊地区的植物卡朱卡拉巴豆树皮提取物中获得的活性成分反式脱氢巴豆素(t-DCTN)三个剂量在瑞士小鼠体内的抗基因毒性作用。小鼠接受急性腹腔注射和灌胃处理,随后通过微核(MN)和染色体畸变(CA)试验分析其骨髓细胞。对t-DCTN的三个剂量组与阴性对照组进行了比较。统计分析表明,通过腹腔注射或灌胃给予50%和75% LD(50)剂量的t-DCTN对环磷酰胺具有抗诱变作用。然而,25% LD(50)剂量仅在灌胃给药时具有抗诱变作用。基于这些观察结果,可以认为灌胃是给予t-DCTN最有效的方法。此外,无论暴露途径如何,t-DCTN在骨髓细胞中均未显示出细胞毒性作用。